Unmoderated Poster Session Unmoderated Poster Session 3| Volume 78, ISSUE 3, SUPPLEMENT , S360, September 2011

UP-03.052 Combination of Andropenis® Penile Extender and Oral Therapy (Peironimev ®) Versus Intralesional Verpamil for Penile Curvature Due To Peyronie's Disease: Preliminary Results of a Randomized Phase II Trial

      Intralesional Verapamil is a commonly used treatment option for Peyronie's disease. Concern exists as regards its relative invasiveness and patients' compliance. Preliminary experience suggests that penile extenders may be effective in reducing penile curvature. Aim of the current study was to compare the efficacy and tolerability of the penile extender Andropenis® with intralesional Verapamil. An oral combination of paraminobenzoate and antioxidants (PeironiMEV ®), suggested to be active on the plaque, was added to the penile stretcher arm.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect